U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494201) titled 'MIMICC Study in Patients With Colorectal Cancer' on March 20.
Brief Summary: This multicenter prospective interventional study will evaluate stool and saliva microRNA expression and microbiome composition in patients with histologically confirmed colon or rectal cancer during key phases of the diagnostic and therapeutic pathway. The study aims to confirm and refine molecular signatures associated with colorectal cancer, assess the diagnostic and prognostic potential of salivary biomarkers, and characterize dynamic molecular changes during treatment and follow-up
Study Start Date: Sept. 15, 2025
Study Type: INTERVENTIONAL
Conditi...